A new study from Epic Research, a health analytics firm based in Verona, Wisconsin, detected some encouraging news for those who suffer from cystic fibrosis (CF). In 2008, the average life expectancy ...
The Cystic Fibrosis Center now has multiple patients in their 70s. “I used to say, ‘My job is to turn you into a little old lady or a little old man, and I need your help to do that,’” he said.
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...
The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...
So far, based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing ...
BOSTON — With the remarkable advances made in therapy over the past decade, many patients with cystic fibrosis (CF) can expect to survive into their 50s and even well beyond. But as patients with CF ...
Patients with cystic fibrosis (CF) who did not receive a lung transplant developed cardiovascular disease, kidney problems, and cancer at higher rates than those without CF. Those with CF who did ...
During the 1950s, a child with cystic fibrosis rarely lived long enough to attend elementary school. Today, many people with CF are achieving their dreams of pursuing careers, getting married, having ...
Positive interim safety results from the first two dose escalation cohorts, referred to as Cohorts 1 and 2, were reported in 4Q 2024. Today’s update is focused on safety and molecular findings from ...
There are many new drugs to treat cystic fibrosis, but non-white patients are far less likely to receive the latest precision medicines, accord to a new study. These drugs were approved by the U.S.
Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. The promising thing about this program is that the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results